Clinical News

Medical researchers and physicists are collaborating on oral vaccine research.

Studies indicate a lack of deprescribing is causing physical and fiscal pain to patients. 

Despite legal restrictions and insufficient regulation, the market for CBD oil is booming. 

The company is donating enough drugs for 200,000 patients for up to 11 years, but does it make up for the high price of the drug?

Finalized rule is a step toward increasing drug pricing transparency.

Physicians have been misapplying the CDC’s 2016 opioid prescribing guideline, causing challenges for some pain patients, according to a new commentary.

Approved regulations allow for some flexibility for drugs that can be redistributed or qualify for manufacturer credit. 

Lack of regulation means protecting public health is pharmacist's duty. 

Women no longer require nine months of contraception post cessation of the drug.

Increase adherence by matching technology to each patient's unique needs.

First-ever dual-drug, single tablet for HIV offers lighter treatment regimen. 

Consumers are using test strips that might lead to inaccurate results. 

New report highlights the dangers of prescription medications beyond opioids. 

The program increased hypertension management rates to 77% in 2017. 

Patients taking PPIs 28.4 times more likely to develop chronic kidney disease. 

Researchers targeting virus' receptors used to enter the body. 

First drug approved for PPD use to remain under REMS program.

Study finds different anticoagulation treatment levels for patients with cognitive problems.

Safety monitoring findings for Shingrix are consistent with clinical trial data.

Pregnancy and menopause are contributing factors.

Scott Gottlieb’s tenure at the FDA was marked by hundreds of generic approvals and aggressive moves against the tobacco industry and vaping.

Updated recommendations for the diagnosis, treatment, prevention, and outbreak management of seasonal influenza. 

Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.

CDC reports seasonal influenza activity remains elevated and widespread throughout U.S.

Hospitals must consider operating mechanisms, educational updates, the behavior of prescribers, and even manufacturer transparency when surviving through drug shortages.

2018 marks the 100th anniversary of the Spanish Flu Pandemic, one of the worst pandemics in global history.

Shingrix is in short supply due to high demand, so the maker is upping the supply.

You probably can’t find your perfect job-you’ll have to make it.